GRiP Global Research in Paediatrics – Network of Exclellence
Global Research in Paediatrics – Network of Excellence
GRiP was a European Commission FP7 programme funded project that aimed to develop a joint paediatric clinical pharmacology-training program in collaboration with International stakeholders in order to create a network of well-trained researchers, investigators and experts.
As partner in this project, Penta supported the Azienda Ospedaliera di Padova in project management and the University Tor Vergata in developing and implementing an MSc in Paediatric Medicines Development and Evaluation.
European Medical Information Framework – One platform for data discovery, assessment and (re-)use
EMIF is an Innovative Medicines Initiative Joint Undertaking (IMI-JU), cofunded by the European Commission FP7 programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA) that aims to develop common technical and governance solutions and improve access and use of health data across Europe.
As partner in this project, Penta supports the creation of governance and operating structures within the consortium, assessment of legal and ethical issues, development and implementation of a common data extraction framework, ICT infrastructure and benchmarking, concept and conduct of paediatric use cases to test the viability of the data sharing platform.
This project has received funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115372 resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme and EFPIA in kind contribution.
GAbapentin in Paediatric Pain. Toward new therapies to challenge chronic pain in children
Penta is responsible for scientific coordination of the European Commission FP7 programme funded GAPP project.
This project on gabapentin for the treatment of paediatric chronic neuropathic pain includes development of an age-appropriate formulation and design and implementation of two randomised, comparator- controlled clinical trials and a bridging-modelling study to extrapolate results to younger children.
This project has received funding from the European Union’s 7th FP for research, technological development and demonstration under Grant
By clicking “Accept All” you agree to receive ALL cookies on our Website.
You can reject the cookies that are not “technical and necessary” customizing your choices by clicking on “Cookie settings”.
If you close this banner by clicking the "X" button, default settings will remain in place and you will continue to browse the Website only with “technical and necessary cookies”.
You can review and change your choices at any time by accessing the Management consent panel.